Ocugen announced a regional partnership for OCU400 in Korea.
1 report, 1 independent
Updated Aug 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ocugen announced a regional partnership for OCU400 in Korea.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Ocugen secured exclusive Korean rights for OCU400, and FDA concurrence was granted, enabling BLA submission.Sub-event
Ocugen forms a regional partnership for OCU400 in Korea.1 source
Keep exploring
The entities involved
Related events
- Lee Jae Myung discussed cooperation with OECD during a state visit to France, marking Korea's 30th OECD anniversary.
- Bilateral economic cooperation between Korea and the United States is evolving into a closer partnership.
- Sidi Ould Tah visits Korea for the KOAFEC Ministerial Conference focused on the Korea-Africa economic partnership.
Coverage
Newest first; wire copies grouped- GuruFocus.comOcugen Inc (OCGN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges Cash Equivalents and Restricted Cash: $27.3 million as of June 30, 2025, compared to $58.8 million as